Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Galapagos
sees more deals after Roche agreement 5:06 AM 1/11/2010
Reuters
Belgian biotech Galapagos signed a global development deal with Roche to help single
out ways to tackle chronic obstructive pulmonary disease (COPD).
...
Sanofi's
Vaccine for Mosquito Virus Protects Adults, Study
Says 4:46 AM 1/11/2010
BusinessWeek
Sanofi-Aventis’ experimental vaccine against dengue protected healthy volunteers
against all four strains of the virus.
...
Vertex
sees 2009 loss of less than $650 mln 3:34 AM 1/11/2010
Reuters
Vertex Pharmaceuticals Inc expects to become profitable soon after it begins selling
the hepatitis C treatment telaprevir planning to file a New Drug Application for the drug in the second half of
2010.
...
US
approves Roche's Actemra arthritis drug 5:58 PM 1/8/2010
Reuters
The US FDA has approved Roche Holding's Actemra to treat moderate to
severe rheumatoid arthritis in adults who do not respond well to drugs designed to block inflammatory protein
tumor necrosis factor (TNF).
...
Immunomedics gets patent for lupus drug 1:17 PM 1/8/2010
Reuters
Immunomedics Inc received a US patent for its experimental lupus drug
epratuzumab and other antibodies which target B-cells for the treatment of a range of autoimmune diseases.
...
Cyclacel
shares extend gains on lung cancer drug data 11:32 AM 1/8/2010
Reuters
Cyclacel's drug seliciclib is currently in mid-stage trials for the
treatment of non-small cell lung cancer.
...
Teva
sees revenue more than doubling by 2015 3:42 PM 1/7/2010
Reuters
One-third of Teva's sales growth may come from acquisitions. Teva also targets growing
its share of the US generics market from 22 to 35 percent.
...
Ardea
Biosciences rises on gout drug study results 1:18 PM 1/7/2010
BusinessWeek
Ardea Biosciences Inc said a combination of its RDEA594 and
allopurinol reduced levels of uric acid more than allopurinol alone.
...
Vivus
drug cuts apnea in small trial 7:48 AM 1/7/2010
Reuters
A small trial of Vivus Inc's experimental weight-loss drug Qnexa showed it reduced the
incidence of sleep apnea events by 69 percent.
...
Almirall,
Forest say positive results on lung drug 5:35 AM 1/7/2010
Reuters
Almirall and Forest Laboratories Inc reported positive results from the
Phase III study of chronic obstructive lung disease drug Eklira (aclidinium bromide).
...
AstraZeneca
Settles Nexium Patent Dispute With Teva 4:44 AM 1/7/2010
Wall Street Journal
AstraZeneca ended a long-running patent dispute with Teva Pharmaceutical
Industries over blockbuster heartburn drug Nexium. The deal keeps Teva's generic copies off the US market until
2014.
...
Gilead
Sciences' HIV drug regimen meets mid-stage goal 2:36 AM 1/7/2010
Reuters
Gilead Sciences Inc's results from a mid-stage study showed that its
experimental drug regimen to treat HIV infection met the main goal.
...
Cephalon
Sues Watson Over Sleep Drug Nuvigil 3:06 PM 1/6/2010
ABC News
Cephalon Inc confirmed it is suing generic drug developer Watson Pharmaceuticals Inc
over its plan to make a generic version of sleep disorder drug Nuvigil. Cephalon is already suing generic drug
developer Teva in a similar patent dispute.
...
Biopharmaceutical
Industry Is Banking on Boston 9:09 AM 1/6/2010
New York Times
Biopharmaceutical companies have $2.3 billion in manufacturing plants in
development in the Boston area to produce genetically engineered drugs.
...
Dainippon
Sumitomo applies for US approval of key drug 4:59 AM 1/5/2010
Reuters
Dainippon Sumitomo Pharma applied for US marketing approval of its key
experimental schizophrenia drug lurasidone.
...
<- Day Earlier | Today's News
|
